KeaneW.F., VasS.I.Peritonitis. In: GokalR., NolphK.D. eds. The textbook of peritoneal dialysis.Dordrecht: Kluwer Academic Publishers, 1994: 473–501.
2.
GokalR., JakubowskiC., KingJ.Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicentre study.Lancet1987; ii: 1105–9.
3.
SerkesK.D., BlaggC.R., NolphK.D.Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: a multicentre study.Perit Dial Int1990; 10: 15–19.
4.
MaiorcaR., CancariniG.C., BrunoriG.Morbidity and mortality of CAPD and hemodialysis.Kidney Int1993; 43(Suppl 40): S4–S15.
5.
SwartzR.D.Chronic peritoneal dialysis: mechanical and infectious complications.Nephron1985; 40: 20–37.
6.
GloorH.J., NicholsU.K., SorkinM.I.Peritoneal access and related complications in continuous ambulatory peritoneal dialysis.Am J Med1983; 74: 593–8.
7.
BernardiniJ., HolleyJ.L., JohnstonJ.R.An analysis of infections in adults on continuous ambulatory peritoneal dialysis (CAPD).Clin Nephrol1991; 36: 29–34.
Fenton SSA.Peritonitis-related deaths among CAPD patients.Perit Dial Bull1983; 3: 9–11.
10.
DigenisG.E., AbrahamG., SavinE.Peritonitis related deaths in continuous ambulatory peritoneal dialysis (CAPD) patients.PeritDial Int1990; 10: 45–7.
11.
TzamaloukasA.H., ObermillerL.E., GibelL.J.Peritonitis associated with intra-abdominal pathology in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1993; 13(Suppl 2): S335–7.
12.
WakeenM.J., ZimmermanS.W., BidwellD.Viscus perforation in peritoneal dialysis patients: diagnosis and outcome.Perit Dial Int1994; 14: 371–7.
13.
TranaeusA., HeimbürgerO., LindholmB.Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): diagnostic findings, therapeutic outcome and complications.Perit Dial Int1989; 9: 179–90.
14.
GregoryM.C., DuffyD.P.Toxic shock following staphy-lococcal peritonitis.Clin Nephrol1983; 20: 101–4.
15.
DobbieJ.W.Morphology of the peritoneum in CAPD.Blood Purif1989; 7: 74–85.
16.
GandhiV.C., HuamyunH.M., IngT.S.Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients.Arch Intern Med1980; 140: 1201–3.
17.
KredietR.T., StruijkD.G., BoeschotenE.W.The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis.Am J Kidney Dis1989; 13: 299–307.
18.
PusateriR., RossR., MarshallR.Sclerosing encapsulating peritonitis: report of a case with small bowel obstruction managed by long-term home parenteral hyperalimentation, and a review of the literature.Am J Kidney Dis1986; 8: 56–60.
19.
OulèsR., ChallahS., BrunnerF.P.Case-control study to determine the cause of sclerosing peritoneal disease.Nephrol Dial Transplant1988; 3: 66–9.
20.
SlingeneyerA.Preliminary report on a cooperative international study on sclerosing encapsulating peritonitis.Contrib Nephrol1987; 57: 239–47.
21.
DobbieJ.W.Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.Perit Dial Int1992; 12: 14–27.
22.
RottembourgJ., IssadB., LangloisP.Sclerosing encapsulating peritonitis during CAPD. Evaluation of the potential risk factors. In: MaherJ.F., WinchesterJ.F. eds. Frontiers in peritoneal dialysis.New York: Field, Rich and Assoc. Inc., 1986: 643–9.
23.
LoW.K., ChanK.T., LeungA.L.T.Sclerosingperitonitis complicating prolonged use of chlorhexidine in alcohol in the connection procedure for continuous ambulatory peritoneal dialysis.Perit Dial Int1991; 11: 166–72.
24.
BargmanJ.M.Noninfectious complications of peritoneal dialysis. In: GokalR., NolphK.D. eds. The textbook of peritoneal dialysis.Dordrecht: Kluwer Academic Publishers, 1994: 473–501.
FreimanJ.P., GrahamD.J., ReedT.G.Chemical peritonitis following the intraperitoneal administration of vancomycin.Perit Dial Int1992; 12: 57–60.
27.
StruijkD.G., KredietR.T., BoeschotenE.W.Antifungal treatment of candida peritonitis in continuous ambulatory peritoneal dialysis patients.Am J Kidney Dis1987; 9: 66–70.
28.
SitterT., SpannaglM., SchifflH.Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells.Nephrol Dial Transplant1995; 10: 677–83.
29.
VipondM.N., WhawellS.A., ThompsonJ.N.Peritoneal fibrinolytic activity and intra-abdominal adhesions.Lancet1990; i: 1120–2.
30.
BoeschotenE.W.Peritonitis in CAPD; changes in causative micro-organisms and antimicrobial resistance. In: La GrecaG., RoncoC., FerianiM., ChiaramonteS., ConzP. eds. Peritoneal dialysis.Milano: Wichtig Editore, 1991: 247–57.
31.
MaiorcaR., CantaluppiA., CancariniG.C.Prospective controlled trial of a Y -connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis.Lancet1983; ii: 644–52.
32.
MaiorcaR., CancariniG.C., BrasaS.Y -system with disinfectant in the prevention of peritonitis in CAPD.Contrib Nephrol1987; 17: 178–84.
33.
Canadian CAPD Clinical Trials Group.Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multicenter randomized clinical trial comparing the Y connector disinfectant system to standard systems.Perit Dial Int1989; 9: 159–63.
34.
PortF.K., HeldP.J., NolphK.D.Risk of peritonitis and technique failure by CAPD connection technique: a national study.Kidney Int1992; 42: 967–74.
35.
RottembourgJ., BrouardR., IssadB.Prospective randomized study about Y connectors in CAPD patients. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G. eds. Advances in continuous ambulatory peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1987: 107–13.
ZimmermanS.W., O'BrienM., WiedenhoeftF.A.Staphylococcus aureus peritoneal catheter-related infections: a cause of catheter loss and peritonitis.Perit Dial Int1988; 8: 191–4.
38.
LuzarM.A., ColesG.A., FallerB.Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis.N Engl J Med1990; 322: 505–9.
39.
ChurchillD.N.CAPD peritonitis: a critical appraisal of prophylactic strategies.Semin Dial1991; 4: 94–100.
40.
AtkinsR.C., HumpheryT., ThomsonN.Efficacy of treatment in CAPD peritonitis -the problem of staphylococcal antibiotic resistance. In: AtkinsR.C., ThomsonN.M., FarrellP.C. eds. Peritoneal dialysis.Edinburgh: Churchill Livingstone1981: 337–9.
41.
ChongT.K., PirainoB., BernardiniJ.Vestibular toxicity due to gentamicin in peritoneal dialysis patients.Perit Dial Int1991; 11: 152–5.
Van der HulstR.J., BoeschotenE.W., NielsenF.W.Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin.Oto Rhino Laryngology1991; 53: 19–23.
